Fiorino G - Search Results

1

Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.

Armuzzi A, Pugliese D, Danese S, Rizzo G, Felice C, Marzo M, Andrisani G, Fiorino G, Nardone OM, De Vitis I, Papa A, Rapaccini GL, Guidi L. Armuzzi A, et al. Among authors: fiorino g. Inflamm Bowel Dis. 2014 Aug;20(8):1368-74. doi: 10.1097/MIB.0000000000000115. Inflamm Bowel Dis. 2014. PMID: 24983979

2

Emerging biologics in the treatment of inflammatory bowel disease: what is around the corner?

Fiorino G, Rovida S, Correale C, Malesci A, Danese S. Fiorino G, et al. Curr Drug Targets. 2010 Feb;11(2):249-60. doi: 10.2174/138945010790309975. Curr Drug Targets. 2010. PMID: 20210771 Review.

3

Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study.

Danese S, Fiorino G, Angelucci E, Vetrano S, Pagano N, Rando G, Spinelli A, Malesci A, Repici A. Danese S, et al. Among authors: fiorino g. World J Gastroenterol. 2010 May 21;16(19):2396-400. doi: 10.3748/wjg.v16.i19.2396. World J Gastroenterol. 2010. PMID: 20480525 Free PMC article.

4

Leukocyte traffic control: a novel therapeutic strategy for inflammatory bowel disease.

Fiorino G, Correale C, Fries W, Repici A, Malesci A, Danese S. Fiorino G, et al. Expert Rev Clin Immunol. 2010 Jul;6(4):567-72. doi: 10.1586/eci.10.40. Expert Rev Clin Immunol. 2010. PMID: 20594130

5

Adalimumab in ulcerative colitis: hypes and hopes.

Fiorino G, Peyrin-Biroulet L, Repici A, Malesci A, Danese S. Fiorino G, et al. Expert Opin Biol Ther. 2011 Jan;11(1):109-16. doi: 10.1517/14712598.2011.541435. Expert Opin Biol Ther. 2011. PMID: 21133817 Review.

6

Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease.

Rutella S, Fiorino G, Vetrano S, Correale C, Spinelli A, Pagano N, Arena V, Maggiano N, Repici A, Malesci A, Danese S. Rutella S, et al. Among authors: fiorino g. Am J Gastroenterol. 2011 Apr;106(4):762-70. doi: 10.1038/ajg.2011.48. Epub 2011 Mar 1. Am J Gastroenterol. 2011. PMID: 21364546

7

Acute severe colitis: infliximab and/or cyclosporine?

Fabro M, Szabo H, Terrosu G, Avellini C, Tabuso M, Fiorino G, Sorrentino D. Fabro M, et al. Among authors: fiorino g. Curr Drug Targets. 2011 Sep;12(10):1448-53. doi: 10.2174/138945011796818234. Curr Drug Targets. 2011. PMID: 21466485 Review.

8

Mucosal healing in ulcerative colitis: where do we stand?

Fiorino G, Cesarini M, Indriolo A, Malesci A. Fiorino G, et al. Curr Drug Targets. 2011 Sep;12(10):1417-23. doi: 10.2174/138945011796818216. Curr Drug Targets. 2011. PMID: 21466490 Review.

9

Biological therapy for ulcerative colitis: what is after anti-TNF.

Fiorino G, Cesarini M, Danese S. Fiorino G, et al. Curr Drug Targets. 2011 Sep;12(10):1433-9. doi: 10.2174/138945011796818225. Curr Drug Targets. 2011. PMID: 21466492 Review.

10

Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study.

Fiorino G, Peyrin-Biroulet L, Naccarato P, Szabò H, Sociale OR, Vetrano S, Fries W, Montanelli A, Repici A, Malesci A, Danese S. Fiorino G, et al. Inflamm Bowel Dis. 2012 Jun;18(6):1042-7. doi: 10.1002/ibd.21800. Epub 2011 Jun 14. Inflamm Bowel Dis. 2012. PMID: 21674732 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters